BioCrossroads | Crossroads Health Ventures
◆ Fund Size
$21M
◆ Check Size
◆ Location
United States
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Targeted early-stage investment into life sciences startups to translate research strengths into high-growth companies in Indiana.
◆ About BioCrossroads
Crossroads Health Ventures is an early-stage venture capital firm focused on life sciences innovations in human, animal, and plant health. It invests in U.S.-based startups, with a preference for Indiana companies, providing capital, industry expertise, and networks through strategic limited partners like Lilly Ventures, Elanco, and Corteva. The firm supports companies from pre-seed through Series A+ to bridge funding gaps and accelerate commercialization.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Emily Atkinson, PhD | Senior Director of Innovation | senior | |
| Mike Bolinder | Senior Vice President, External Engagement & Chief Innovation Officer | senior | |
| Samantha Ginther | Principal, Senior Director | senior | |
| Vince Wong | President & CEO | senior |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Crossroads Health Ventures invest in?
Crossroads Health Ventures invests in Biotech, Digital Health, Diagnostics, Drug Discovery and Medtech at the pre-seed and seed stages.
Which geographies does Crossroads Health Ventures focus on?
Crossroads Health Ventures focuses on United States, and is headquartered in United States.
What is Crossroads Health Ventures's typical check size?
Crossroads Health Ventures typically writes checks of $0.1M to $5M.